Analysis of associations of candidate gene polymorphism with the development of knee osteoarthritis in obese patients
https://doi.org/10.25789/YMJ.2023.83.17
Abstract
Background. Knee Osteoarthritis (OA) is a chronic disease with multifactorial pathogenesis. Risk factors for developing knee OA include age, genetic predisposition, and obesity. The share of genetic factors in the development of the disease accounts for up to 50 %. Despite the obvious association between obesity and knee OA, studies that reveal the role of genetic factors in the development of the disease in the interaction with obesity or overweight are extremely limited.
The aim of the study: To study the association of candidate genes polymorphic loci GDF5 (rs143384), NFAT5 (rs6499244), WWP2 (rs34195470), SBNO1 (rs1060105, rs56116847) with the development of knee OA in patients with obesity.
Materials and methods. The sample for the study included 322 obese individuals: 255 patients with OA of the knee and 67 people in the control group. Genotyping of DNA samples from all study participants was performed using standard real-time PCR on CFX96 amplifier (USA). Associations of genetic markers with knee OA in obese patients were assessed using the odds ratio and 95 % confidence interval.
Results. Analysis of the associations of the studied polymorphic loci with the development of knee OA in obese patients revealed significant differences only for the GDF5 (rs143384) gene polymorphism. It was established that the frequency of the G/G genotype rs143384 in obese knee OA patients was 14.12 %, which is 1.8 times less compared to the control (25.36 %, p = 0.043, OR = 0.48).
Conclusions. The modifying role of obesity on the nature of the rs143384 polymorphic marker GDF5 gene associations with the developing knee OA in the population of the Russia Central Chernozem Region was shown. The G/G genotype rs143384 was found to be a protective factor in the development of knee OA in obese patients.
About the Authors
V. B. NovakovRussian Federation
NOVAKOV Vitaly B. – orthopaedic surgeon, City Hospital №2 of Belgorod; postgraduate student, Belgorod State National Research University
O. N. Novakova
Russian Federation
NOVAKOVA Olga N. – PhD (Biol.), Associate Professor of the Department of Biomedical Sciences of the Medical Institute
M. I. Churnosov
Russian Federation
CHURNOSOV Mikhail I. – MD (Med.), Professor, head of the Department of Biomedical Sciences of the Medical Institute
References
1. Genetic markers of knee osteoarthritis in women of the Central Chernozem region of Russia / Novakov V.B. [et al.] // Research Results in Biomedicine]. 2023. Vol. 9. No. 2. P. 191–205. DOI:10.18413/2658-6533-2023-9-2-0-4.
2. .Lisitsyn M.P., Zaremuk A.M., Atlukhanov R.Ya. Knee arthroscopy for gonarthritis // Endoscopic Surgery. 2019. Vol. 25. No. 4. P. 55–64. DOI:10.17116/endoskop20192504155.
3. Polonikov A.V., Klyosova E.Yu., Azarova I.E. Bioinformatic tools and internet resources for functional annotation of polymorphic loci detected by genome wide association studies of multifactorial diseases (review) // Research Results in Biomedicine. 2021. Vol. 7. No. 1. P. 15–31. DOI:10.18413/2658-6533-2020-7-1-0-2.
4. A cross-population atlas of genetic associations for 220 human phenotypes / Sakaue S. [et al.] // Nat Genet. 2021. Vol. 53. No 10. P. 1415– 1424. DOI:10.1038/s41588-021-00931-x.
5. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations / Boer C.G. [et al.] // Cell. 2021. Vol. 184. No 18. P. 4784–4818.e17. DOI:10.1016/j.cell.2021.07.038.
6. Epidemiology of osteoarthritis / Allen K.D. [et al.] // Osteoarthr Cartil. 2022. Vol. 30. P. 184– 195. DOI:10.1016/j.joca.2021.04.020.
7. Genetic and Epigenetic Interactions in the Etiopathogenesis of Osteoarthritis. Selected Molecular Factors in OA Etiopathogenesis / Snochowska A. [et al.] // Ortop Traumatol Rehabil. 2017. Vol. 19. No 3. P. 227–237. DOI:10.5604/15093492.1240791.
8. Genome-wide association meta-analysis of knee and hip osteoarthritis uncovers genetic differences between patients treated with joint replacement and patients without joint replacement / Henkel C. [et al.] // Ann Rheum Dis. 2023. Vol. 82. No 3. P. 384–392. DOI:10.1136/ard-2022-223199.
9. Genome-wide association study of body fat distribution identifies adiposity loci and sex-specific genetic effects / Rask-Andersen M. [et al.] // Nat Commun. 2019. Vol. 10. No 1. P. 339. DOI:10.1038/s41467-018-08000-4.
10. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 / Safiri S. [et al.] // Ann Rheum Dis. 2020. Vol. 79. No 6. P. 819–828. DOI:10.1136/annrheumdis-2019-216515.
11. Growth differentiation factor-5 enhances in vitro mesenchymal stromal cell chondrogenesis and hypertrophy / Coleman C.M. [et al.] // Stem Cells Dev. 2013. Vol. 22. No 13. P. 1968–1976. DOI:10.1089/scd.2012.0282.
12. Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure / Hinoi E. [et al.] // Diabetes. 2014. Vol. 63. No 1. P. 162–175. DOI:10.2337/db13-0808.
13. GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer / Christakoudi S. [et al.] // Sci Rep. 2021. Vol. 11. No 1. P 10688. DOI:10.1038/s41598-021-89176-6.
14. GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures / Styrkarsdottir U. [et al.] // Nat Commun. 2019. Vol. 10. No 1. P. 2054. DOI:10.1038/s41467-019-09860-0.
15. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data / Tachmazidou I. [et al.] // Nat Genet. 2019. Vol. 51, No 2. P 230–236. DOI:10.1038/s41588-018-0327-1.
16. Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? / An Update. Giorgino R. [et al.] // Int J Mol Sci. 2023. Vol. 24. No 7. P. 6405. DOI:10.3390/ijms24076405.
17. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty / Losina E. [et al.] // Arthritis Care Res (Hoboken). 2015. Vol. 67. No 2. P. 203–215. DOI:10.1002/acr.22412.
18. Mechanisms of GDF-5 action during skeletal development / Francis-West P.H. [et al.] // Development. 1999. Vol. 126. No 6. P. 1305–1315. DOI:10.1242/dev.126.6.1305.
19. Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis / Styrkarsdottir U. [et al.] // Nat Genet. 2018. Vol. 50. No 12. P. 1681–1687. DOI:10.1038/s41588-018-0247-0.
20. Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis / Kania K. [et al.] // Sci Rep. 2020. Vol. 10. No 1. P. 157. DOI:10.1038/s41598-019-57011-8.
21. Systemic and local adipose tissue in knee osteoarthritis / Chang J. [et al.] // Osteoarthr Cartil. 2018. Vol. 26. No 7. P. 864–871. DOI:10.1016/j.joca.2018.03.004.
22. Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice / Yang Y. [et al.] // Can J Gastroenterol Hepatol. 2021. Vol. 2021. P. 8894685. DOI:10.1155/2021/8894685.
23. The contribution of genetics and environment to obesity / Albuquerque D. [et al.] // Br Med Bull. 2017. Vol. 123. No 1. P. 159–173. DOI:10.1093/bmb/ldx022.
24. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study / Cross M. [et al.] // Ann Rheum Dis. 2014. Vol. 73. No 7. P. 1323–1330. DOI:10.1136/annrheumdis-2013-204763.
25. Zengini E., Finan C., Wilkinson J.M. The Genetic Epidemiological Landscape of Hip and Knee Osteoarthritis: Where Are We Now and Where Are We Going? // J Rheumatol. 2016. Vol. 43.No 2. P. 260–266. DOI:10.3899/jrheum.150710.
Review
For citations:
Novakov V.B., Novakova O.N., Churnosov M.I. Analysis of associations of candidate gene polymorphism with the development of knee osteoarthritis in obese patients. Yakut Medical Journal. 2023;(3):68-71. https://doi.org/10.25789/YMJ.2023.83.17